                         SEQUENCE LISTING

<110>  La Jolla Institute for Allergy and Immunology
 
<120>  ZIKA PEPTIDE SEQUENCES, EPITOPES, AND METHODS AND USES THEREOF

<130>  2016-103-03

<150>  US 62/457,753
<151>  2017-02-10

<160>  96    

<170>  PatentIn version 3.5

<210>  1
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes, E protein 600-607

<400>  1

Ala Ala Phe Thr Phe Thr Lys Val 
1               5               


<210>  2
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes, NS2B protein 1489-1497

<400>  2

Ala Ala Gly Ala Trp Tyr Val Tyr Val 
1               5                   


<210>  3
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes, PrM protein 145-153

<400>  3

Ile Ser Phe Ala Thr Thr Leu Gly Val 
1               5                   


<210>  4
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes, PrM protein 171-178

<400>  4

Met Ser Tyr Glu Cys Pro Met Leu 
1               5               


<210>  5
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS3 1866-1874

<400>  5

Pro Ser Val Arg Asn Gly Asn Glu Ile 
1               5                   


<210>  6
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS5 2993-3000

<400>  6

Arg Ala Ile Trp Tyr Met Trp Leu 
1               5               


<210>  7
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS5 2892-2902

<400>  7

Arg Gln Val Met Asn Ile Val Ser Ser Trp Leu 
1               5                   10      


<210>  8
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS3 1795-1803

<400>  8

Ser Ser Ile Ala Ala Arg Gly Tyr Ile 
1               5                   


<210>  9
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS5 2839-2848

<400>  9

Ser Ser Leu Val Asn Gly Val Val Arg Leu 
1               5                   10  


<210>  10
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS5 2899-2906

<400>  10

Ser Ser Trp Leu Trp Lys Glu Leu 
1               5               


<210>  11
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS5 3220-3228

<400>  11

Thr Gly Trp Ser Asn Trp Glu Glu Val 
1               5                   


<210>  12
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes E 338-346

<400>  12

Thr Thr Val Ser Asn Met Ala Glu Val 
1               5                   


<210>  13
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes E 784-792

<400>  13

Val Met Ile Phe Leu Ser Thr Ala Val 
1               5                   


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS1 969-978

<400>  14

Tyr Ser Leu Glu Cys Asp Pro Ala Val Ile 
1               5                   10  


<210>  15
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes E 600-607

<400>  15

Ala Ala Phe Thr Phe Thr Lys Ile 
1               5               


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS5 2839-2848

<400>  16

Ser Ser Leu Ile Asn Gly Val Val Arg Leu 
1               5                   10  


<210>  17
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes PrM 150-158

<400>  17

Thr Leu Gly Met Asn Lys Cys Tyr Ile 
1               5                   


<210>  18
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS4A 2257-2264

<400>  18

Ile Met Val Ala Val Gly Leu Leu 
1               5               


<210>  19
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes PrM 169-177

<400>  19

Ala Thr Met Ser Tyr Glu Cys Pro Met 
1               5                   


<210>  20
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS5 2783-2792

<400>  20

Cys Ala Glu Ala Pro Asn Met Lys Val Ile 
1               5                   10  


<210>  21
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes E 294-302

<400>  21

Ile Gly Val Ser Asn Arg Asp Phe Val 
1               5                   


<210>  22
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes E 635-645

<400>  22

Met Ala Val Asp Met Gln Thr Leu Thr Pro Val 
1               5                   10      


<210>  23
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes E 710-718

<400>  23

Arg Met Ala Val Leu Gly Asp Thr Ala 
1               5                   


<210>  24
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes E 347-355

<400>  24

Arg Ser Tyr Cys Tyr Glu Ala Ser Ile 
1               5                   


<210>  25
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes E 297-305

<400>  25

Ser Asn Arg Asp Phe Val Glu Gly Met 
1               5                   


<210>  26
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS4B 2371-2379

<400>  26

Ser Gln Leu Thr Pro Leu Thr Leu Ile 
1               5                   


<210>  27
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS2A 1336-1345

<400>  27

Ser Val Lys Lys Asn Leu Pro Phe Val Met 
1               5                   10  


<210>  28
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS2A 1237-1244

<400>  28

Val Ser Phe Ile Phe Arg Ala Asn 
1               5               


<210>  29
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived epitopes NS3 1656-1664

<400>  29

Val Val Ile Lys Asn Gly Ser Tyr Val 
1               5                   


<210>  30
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA-restricted epitopes C 25-35

<400>  30

Ser Pro Phe Gly Gly Leu Lys Arg Leu Pro Ala 
1               5                   10      


<210>  31
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA-restricted epitopes MR-M 4-12

<400>  31

Leu Pro Ser His Ser Thr Arg Lys Leu 
1               5                   


<210>  32
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA-restricted epitopes MR-E 38-45

<400>  32

Lys Pro Thr Val Asp Ile Glu Leu 
1               5               


<210>  33
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA-restricted epitopes MR-E 170-178

<400>  33

Thr Pro Asn Ser Pro Arg Ala Glu Ala 
1               5                   


<210>  34
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA-restricted epitopes MR-E 173-180

<400>  34

Ser Pro Arg Ala Glu Ala Thr Leu 
1               5               


<210>  35
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes MR-E 233-242

<400>  35

Thr Pro His Trp Asn Asn Lys Glu Ala Leu 
1               5                   10  


<210>  36
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes E 337-347

<400>  36

Gly Pro Cys Lys Val Pro Ala Gln Met Ala Val 
1               5                   10      


<210>  37
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes MR-NS 199-107

<400>  37

Gly Pro Gln Arg Leu Pro Val Pro Val 
1               5                   


<210>  38
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS2A 31-40

<400>  38

Val Val Met Ile Leu Gly Gly Phe Ser Met 
1               5                   10  


<210>  39
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes MR-NS2A 75-84

<400>  39

Arg Pro Ala Leu Leu Val Ser Phe Ile Phe 
1               5                   10  


<210>  40
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes MR-NS2A 89-99

<400>  40

Thr Pro Arg Glu Ser Met Leu Leu Ala Leu 
1               5                   10  


<210>  41
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS2A 133-141

<400>  41

Val Pro Arg Thr Asp Asn Ile Thr Leu 
1               5                   


<210>  42
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS2A 133-141

<400>  42

Val Pro Arg Thr Asp Asn Ile Ala Leu 
1               5                   


<210>  43
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS2A 141-150

<400>  43

Leu Pro Ile Leu Ala Ala Leu Thr Pro Leu 
1               5                   10  


<210>  44
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS2A 148-155

<400>  44

Thr Pro Leu Ala Arg Gly Thr Leu 
1               5               


<210>  45
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS2B 68-75

<400>  45

Ser Pro Arg Leu Asp Val Ala Leu 
1               5               


<210>  46
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS3 188-196

<400>  46

Leu Pro Glu Ile Val Arg Glu Ala Ile 
1               5                   


<210>  47
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS3 206-215

<400>  47

Ala Pro Thr Arg Val Val Ala Ala Glu Met 
1               5                   10  


<210>  48
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS3 309-317

<400>  48

Phe Pro Asp Ser Asn Ser Pro Ile Met 
1               5                   


<210>  49
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS3 405-413

<400>  49

Arg Val Ile Asp Ser Arg Arg Cys Leu 
1               5                   


<210>  50
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS3 427-436

<400>  50

Gly Pro Met Pro Val Thr His Ala Ser Ala 
1               5                   10  


<210>  51
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS3 492-501

<400>  51

Arg Pro Glu Ala Asp Lys Val Ala Ala Ile 
1               5                   10  


<210>  52
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS3 574-582

<400>  52

Lys Pro Arg Trp Met Asp Ala Arg Val 
1               5                   


<210>  53
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS3 581-589

<400>  53

Arg Val Cys Ser Asp His Ala Ala Leu 
1               5                   


<210>  54
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS 3596-NS4A1

<400>  54

Ala Ala Gly Lys Arg Gly Ala Ala Leu 
1               5                   


<210>  55
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS4A 36-45

<400>  55

Arg Pro Tyr Lys Ala Ala Ala Ala Gln Leu 
1               5                   10  


<210>  56
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS4A 125-133

<400>  56

Ser Pro Gln Asp Asn Gln Met Ala Ile 
1               5                   


<210>  57
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS4B 35-44

<400>  57

Arg Pro Ala Ser Ala Trp Ala Ile Tyr Ala 
1               5                   10  


<210>  58
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS4B 105-115

<400>  58

Thr Pro Leu Thr Leu Ile Val Ala Ile Ile Leu 
1               5                   10      


<210>  59
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS4B 210-220

<400>  59

Ser Pro Asn Lys Tyr Trp Asn Ser Ser Thr Ala 
1               5                   10      


<210>  60
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS4B 426-435

<400>  60

Arg Pro Gly Ala Phe Cys Ile Lys Val Leu 
1               5                   10  


<210>  61
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS5 61-70

<400>  61

Ala Pro Thr Gln Gly Ser Ala Ser Ser Leu 
1               5                   10  


<210>  62
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS5 140-149

<400>  62

Arg Pro Arg Val Cys Thr Lys Glu Glu Phe 
1               5                   10  


<210>  63
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS5 332-341

<400>  63

Arg Pro Ala Glu Gly Gly Lys Thr Val Met 
1               5                   10  


<210>  64
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS5 539-546

<400>  64

Val Pro Thr Gly Arg Thr Thr Trp 
1               5               


<210>  65
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS5 587-596

<400>  65

Ile Pro Tyr Leu Gly Lys Arg Glu Asp Leu 
1               5                   10  


<210>  66
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS5 605-614

<400>  66

Arg Pro Arg Thr Thr Trp Ala Glu Asn Ile 
1               5                   10  


<210>  67
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes C125-prM8

<400>  67

Val Thr Arg Arg Gly Asn Ala Tyr Tyr 
1               5                   


<210>  68
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes prM 40-48

<400>  68

His Met Cys Asp Ala Thr Met Ser Tyr 
1               5                   


<210>  69
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes E 81-90

<400>  69

Tyr Leu Asp Lys Gln Ser Asp Thr Gln Tyr 
1               5                   10  


<210>  70
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes E 159-167

<400>  70

Glu Thr Asp Glu Asn Arg Ala Lys Val 
1               5                   


<210>  71
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes E 195-203

<400>  71

Gly Leu Asp Phe Ser Asp Leu Tyr Tyr 
1               5                   


<210>  72
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes E 198-206

<400>  72

Phe Ser Asp Leu Tyr Tyr Leu Thr Met 
1               5                   


<210>  73
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes E 377-386

<400>  73

Glu Leu Asp Pro Pro Phe Gly Asp Ser Tyr 
1               5                   10  


<210>  74
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS1 23-31

<400>  74

Asp Val Glu Ala Trp Arg Asp Arg Tyr 
1               5                   


<210>  75
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS3 272-280

<400>  75

Phe Thr Asp Pro Ser Ser Ile Ala Ala 
1               5                   


<210>  76
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS4A 14-22

<400>  76

Met Thr Glu Arg Phe Gln Glu Ala Ile 
1               5                   


<210>  77
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS4B 231-239

<400>  77

Tyr Leu Ala Gly Ala Ser Leu Ile Tyr 
1               5                   


<210>  78
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS4B 270-278

<400>  78

Met Ser Ala Leu Glu Phe Tyr Ser Tyr 
1               5                   


<210>  79
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  ZIKV-derived HLA restricted epitopes NS5 509-517

<400>  79

Tyr Ala Gln Met Trp Gln Leu Leu Tyr 
1               5                   


<210>  80
<211>  14
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Hepatitis C virus (HCV)-core helper peptide restricted by mouse 
       MHC molecule I-Ab

<400>  80

Thr Pro Pro Ala Tyr Arg Arg Pro Pro Asn Ala Pro Ile Leu 
1               5                   10                  


<210>  81
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS2A 74-83

<400>  81

Arg Pro Thr Phe Ala Ala Gly Leu Leu Leu 
1               5                   10  


<210>  82
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS3 575-583

<400>  82

Lys Pro Arg Trp Leu Asp Ala Arg Ile 
1               5                   


<210>  83
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS4B 423-432

<400>  83

Asn Thr Gln Phe Cys Ile Lys Val Leu 
1               5                   


<210>  84
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS5 538-545

<400>  84

Val Pro Thr Ser Arg Thr Thr Trp 
1               5               


<210>  85
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS5 140-149

<400>  85

Thr Pro Arg Met Cys Thr Arg Glu Glu Phe 
1               5                   10  


<210>  86
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS3187-195

<400>  86

Leu Pro Ala Ile Val Arg Glu Ala Ile 
1               5                   


<210>  87
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS2A 31-40

<400>  87

Val Thr Leu Ile Thr Gly Asn Met Ser Phe 
1               5                   10  


<210>  88
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS2A 87-97

<400>  88

Thr Ser Lys Glu Leu Met Met Thr Thr Ile 
1               5                   10  


<210>  89
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS3 428-437

<400>  89

Gly Pro Met Pro Val Thr His Ser Ser Ala 
1               5                   10  


<210>  90
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS4B 208-218

<400>  90

Asn Pro Gly Arg Phe Trp Asn Thr Thr Ile Ala 
1               5                   10      


<210>  91
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS5 61-70

<400>  91

Thr Lys Gln Thr Gly Ser Ala Ser Ser Met 
1               5                   10  


<210>  92
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-E 38-45

<400>  92

Lys Pro Thr Leu Asp Phe Glu Leu 
1               5               


<210>  93
<211>  9
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  DENV2-NS3 582-590

<400>  93

Arg Ile Tyr Ser Asp Pro Leu Ala Leu 
1               5                   


<210>  94
<211>  23
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  forward primer to detect ZIKV RNA

<400>  94
ttggtcatga tactgctgat tgc                                               23


<210>  95
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Reverse primer to detect ZIKV RNA

<400>  95
ccttccacaa agtccctatt gc                                                22


<210>  96
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Probe to detect ZIKV RNA


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  6-FAM

<220>
<221>  misc_feature
<222>  (27)..(27)
<223>  Tamra-Q

<400>  96
cggcatacag catcaggtgc ataggag                                           27


